Cargando…
Platinum-crosslinking polymeric nanoparticle for synergetic chemoradiotherapy of nasopharyngeal carcinoma
Despite extensive use of radiotherapy in nasopharyngeal carcinoma (NPC) treatment because of its high radiosensitivity, there have been huge challenges in further improving therapeutic effect, meanwhile obviously reducing radiation damage. To this end, synergistic chemoradiotherapy has emerged as a...
Autores principales: | Ding, Yuxun, Xiao, Xiaohui, Zeng, Lingli, Shang, Qiuping, Jiang, Wei, Xiong, Sha, Duan, Xiaohui, Shen, Jun, Wang, Ruibing, Guo, Jinshan, Pan, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164009/ https://www.ncbi.nlm.nih.gov/pubmed/34095627 http://dx.doi.org/10.1016/j.bioactmat.2021.05.010 |
Ejemplares similares
-
Nimotuzumab plus platinum-based chemotherapy versus
platinum-based chemotherapy alone in patients with recurrent or metastatic
nasopharyngeal carcinoma
por: Zhu, Yunshu, et al.
Publicado: (2020) -
Platinum prodrug nanoparticles inhibiting tumor recurrence and metastasis by concurrent chemoradiotherapy
por: Jiang, Wei, et al.
Publicado: (2022) -
High expression of XPA confers poor prognosis for nasopharyngeal carcinoma patients treated with platinum-based chemoradiotherapy
por: Fu, Xiang, et al.
Publicado: (2015) -
Synergetic interaction between neighboring platinum and ruthenium monomers boosts CO oxidation
por: Zhou, Peng, et al.
Publicado: (2019) -
Correction to: Platinum prodrug nanoparticles inhibiting tumor recurrence and metastasis by concurrent chemoradiotherapy
por: Jiang, Wei, et al.
Publicado: (2022)